Year-End Report

THE GORLIN GROUP for AMERICAN BIOINDUSTRY ALLIANCE

Firm
Client
Income
$40,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

Encouraged the Congress and Executive Branch to oppose any attempts by foreign governments to negotiate new international agreements or to amend existing intellectual property agreements in the WTO and WIPO to weaken patent protection for biotechnology inventions. Encouraged the Congress and the Executive Branch to oppose the inclusion of genetic source disclosure requirements for the patenting of biotechnology inventions in any ABS regime negotiated in the CBD.

LobbyistCovered position, as disclosed
JACQUES J GORLIN N/A

Contacted: HOUSE OF REPRESENTATIVES; Patent & Trademark Office (PTO); Commerce, Dept of (DOC); State, Dept of (DOS); SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.